Performance of bowel preparation quality scales in patients with Crohn's disease
Virginia Solitano(Western University), Vipul Jairath(McMaster University), Bryan Maguire, Christopher Ma(University of Calgary), Brian G. Feagan(Western University), Rocío Sedaño, Brian Bressler(University of British Columbia), Guangyong Zou(Western University), Joshua R. Korzenik(Harvard University), Corey A. Siegel(Dartmouth–Hitchcock Medical Center), Douglas K. Rex(Indiana University School of Medicine), Jennifer K. Maratt(Indiana University Melvin and Bren Simon Comprehensive Cancer Center), J. Großmann, Julie Rémillard, John WD McDonald, Lisa M. Shackelton
Cited by 5
Related Papers
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k